Abstract: A computing device includes at least one memory, and at least one processor configured to generate, based on first analysis on a pathological slide image, first biomarker expression information, generate, based on a user input for updating at least some of results of the first analysis, second biomarker expression information about the pathological slide image, and control a display device to output a report including medical information about at least some regions included in the pathological slide image, based on at least one of the first biomarker expression information or the second biomarker expression information.

Abstract: The present invention relates to a polycyclic compound which can be employed in various organic layers included in an organic light emitting device and contains R substituted with at least one deuterium (D), and to an organic light emitting device which has a long lifespan by comprising same to significantly improve lifespan characteristics thereof. According to the present invention, an organic light emitting device having a long lifespan can be implemented, and thus can be industrially advantageously used in various lighting and display devices, such as a flat panel display device, a flexible display device, a monochromatic or white flat panel lighting device, a monochromatic or white flexible lighting device, a vehicle display device, and a virtual or augmented reality display device.

Abstract: The present invention relates to a polycyclic compound that can be employed in various organic layers provided in an organic light-emitting device, and to a high-efficiency and long-life organic light-emitting device which comprises same and thus has significantly improved luminous efficiency and lifespan characteristics. The organic light-emitting device comprising the polycyclic compound according to the present invention can be industrially usefully used for various display devices as well as a lighting device, such as a flat-panel display device, a flexible display device, a monochromatic or white flat-panel lighting device, a monochrome or white flexible lighting device, a vehicle display device, or a virtual or augmented-reality display device.

Abstract: The present invention relates to: a polycyclic compound that can be employed in various organic layers provided in an organic light-emitting device; and a high-efficiency and long-lifespan organic light-emitting device comprising same to have significantly improved luminous efficiency and lifespan characteristics. By using same, the present invention can be industrially and effectively used in lighting devices and various display devices, such as a flat-panel display apparatus, a flexible display apparatus, a monochrome or white flat-panel lighting apparatus, a monochrome or white flexible lighting apparatus, a vehicle display apparatus, and a virtual or augmented reality display apparatus.

Abstract: The present invention relates to an anthracene compound represented by [Chemical Formula A] and an organic light-emitting diode comprising same, wherein [Formula A] is the same as described in the description.

Abstract: Disclosed is a polycyclic compound that can be employed in various organic layers of an organic electroluminescent device. Also disclosed is an organic electroluminescent device including the polycyclic compound. The organic electroluminescent device includes a light emitting layer employing the polycyclic compound as a dopant and an anthracene derivative having a characteristic structure and characteristic substituents as a host. The use of the polycyclic compound significantly improves the color purity, luminous efficiency, and life characteristics of the organic electroluminescent device and makes the organic electroluminescent device highly efficient and long lasting.

Abstract: Disclosed is a polycyclic compound that can be employed in various organic layers of an organic electroluminescent device. The polycyclic compound has a characteristic skeleton structure and characteristic substituents. Also disclosed is an organic electroluminescent device including the polycyclic compound. The organic electroluminescent device includes a light emitting layer employing the polycyclic compound as a dopant and an anthracene derivative having a characteristic structure as a host. The use of the polycyclic compound significantly improves the luminous efficiency and life characteristics of the organic electroluminescent device and makes the organic electroluminescent device highly efficient and long lasting.

Abstract: Disclosed is a polycyclic compound that can be employed in various organic layers of an organic electroluminescent device. The polycyclic compound has a characteristic skeleton structure and characteristic substituents. Also disclosed is an organic electroluminescent device including the polycyclic compound. The organic electroluminescent device includes a light emitting layer employing the polycyclic compound as a dopant and an anthracene derivative having a characteristic structure as a host. The use of the polycyclic compound significantly improves the luminous efficiency and life characteristics of the organic electroluminescent device and makes the organic electroluminescent device highly efficient and long lasting.

Abstract: A method for dedifferentiating adipose tissue stromal cells (ATSC) is provided. When the ATSC is treated under hypoxia condition and with a 4-(3,4-Dihydroxy-phenyl)-derivative (DHP-derivative), expression of stemness genes, cellular growth-related genes and cellular mobility-related genes increase, and expression of histone and DNA methylation-related genes decrease so that cell proliferation increases and pluripotency for differentiating into adipocytes, osteocytes, myocytes, beta cells and cartilage cells is acquired. When the dedifferentiated ATSC is implanted into animal model with spinal cord injury and diabetic animal model, effects of nerve regeneration and increased blood surge level are confirmed. As a result, the method for dedifferentiating the ATSC can be effectively used in the stem cell research, tissue regeneration and development of cytotherapeutic medicines.

Abstract: Provided are a cell therapeutic composition containing selenium, a method of dedifferentiating selenium-treated cells, a cell therapeutic composition containing cells dedifferentiated from the selenium-treated cells by the same method, and a cell therapeutic composition containing cells redifferentiated from the dedifferentiated cells. The dedifferentiated cells, and cells redifferentiated therefrom, can be used to treat a variety of diseases.

Abstract: Provided is a cell therapeutic agent for treatment of neurological disorders, comprising skin-derived progenitor cells (SPCs). More specifically, the present invention provides a cell therapeutic agent for treatment of neurological disorders, comprising skin-derived progenitor cells (SPCs) isolated from skin tissues and a method for differentiation of the skin-derived progenitor cells (SPCs) into neural cell lineages. The cell therapeutic agent in accordance with the present invention is therapeutically effective for the treatment of the neurological disorders and diseases such as Parkinson's disease, Alzheimer's disease, Huntington's disease and Amyotrophic Lateral Sclerosis (ALS) caused by neural injury, and neurological deficits due to cerebral apoplexy, ischemia and spinal cord injury. Further, the present invention enables transplantation of autologous cells to thereby minimize adverse side effects.